Literature DB >> 407825

Renal failure associated with demeclocycline in cirrhosis.

F Carrilho, J Bosch, V Arroyo, A Mas, J Viver, J Rodes.   

Abstract

Three patients with cirrhosis, ascites, and dilutional hyponatremia were treated with demeclocycline in an attempt to correct the abnormal water retention. Demeclocycline administration (600 to 900 mg/day for 8 to 9 days) resulted in [a] increased blood urea nitrogen and plasma creatinine concentrations; [b] reduction of the inulin clearance by between 63% to 78% and of paraaminophippurate clearance by 36% to 77%; and [c] an impairment of the renal concentrating ability. Urine osmolality decreased to hypotonic levels, but polyuria did not appear, probably because it was prevented by the reduction of the glomerular filtration rate. Renal failure was reversible on withdrawal of demeclocycline. No other causes than demeclocycline administration could be found to explain the reduction of the glomerular filtration rate and the estimated renal plasma flow.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 407825     DOI: 10.7326/0003-4819-87-2-195

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  5 in total

1.  Tetracyclines in renal insufficiency: resolution of a therapeutic dilemma.

Authors:  A Whelton
Journal:  Bull N Y Acad Med       Date:  1978-02

2.  Demeclocycline in the treatment of the syndrome of inappropriate secretion of antidiuretic hormone.

Authors:  W H Perks; E H Walters; I P Tams; K Prowse
Journal:  Thorax       Date:  1979-06       Impact factor: 9.139

Review 3.  The management of acute and chronic hyponatraemia.

Authors:  Sarah Jean Lawless; Chris Thompson; Aoife Garrahy
Journal:  Ther Adv Endocrinol Metab       Date:  2022-05-14       Impact factor: 4.435

4.  Demeclocycline therapy for resistant oedema in advanced cardiac failure.

Authors:  R S Bonser; R R Ghose
Journal:  Postgrad Med J       Date:  1980-02       Impact factor: 2.401

Review 5.  Hyponatremia in Patients with Cirrhosis of the Liver.

Authors:  Mauro Bernardi; Carmen Serena Ricci; Luca Santi
Journal:  J Clin Med       Date:  2014-12-31       Impact factor: 4.241

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.